Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 19, 2026

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices
08:26

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Published on: January 30, 2026

Microneedles 2012.

Kate E Broderick1

  • 1Inovio Pharmaceuticals, Inc, San Diego, CA USA. kbroderick@inovio.com

Therapeutic Delivery
|September 6, 2012
PubMed
Summary
This summary is machine-generated.

The second international conference on Microneedles showcased advancements in microneedle technology and applications, fostering interdisciplinary collaboration for drug and vaccine delivery innovations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers.

Frontiers in immunology·2025
Same author

Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults.

Frontiers in immunology·2025
Same author

The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever.

Communications medicine·2024
Same author

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2.

Nature communications·2022
Same author

Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo.

Cell reports. Medicine·2022
Same author

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.

Vaccine·2022
Same journal

Naturally derived excipients in injectable nanomedicines: a systematic review of pharmacokinetic performance, regulatory readiness, and future quality by design perspectives.

Therapeutic delivery·2026
Same journal

Flavonoid nanoformulations for cutaneous administration: overcoming delivery barriers for targeted therapeutics and bioavailability enhancement.

Therapeutic delivery·2026
Same journal

Optimization of nanoemulsion formulations of <i>Piper sarmentosum</i> for topical application in skin cancer.

Therapeutic delivery·2026
Same journal

An evaluation of aripiprazole long-acting injectable monthly and bimonthly in the maintenance treatment of bipolar I disorder.

Therapeutic delivery·2026
Same journal

A decision-support workflow for the selection of mathematical models in drug dissolution and release studies.

Therapeutic delivery·2026
Same journal

Ternary co-encapsulation in electrospun PVA fibers: release kinetics and mechanisms.

Therapeutic delivery·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Pharmaceutical Sciences
  • Nanotechnology

Background:

  • The second International Conference on Microneedles convened in Cork, Ireland (May 2012), building on the success of the 2010 Georgia Tech meeting.
  • This conference served as a pivotal forum for disseminating cutting-edge research and fostering collaborations in microneedle technology.

Purpose of the Study:

  • To report on the key developments and discussions from the second International Conference on Microneedles.
  • To highlight advancements in microneedle design, technology, and applications, particularly in drug and vaccine delivery.

Main Methods:

  • The conference featured a short course on microneedle technology, followed by two days of invited lectures and poster presentations.
  • Sessions covered critical areas including solid and hollow microneedle design, vaccine delivery systems, and drug delivery applications.

More Related Videos

Polymeric Microneedle Array Fabrication by Photolithography
08:15

Polymeric Microneedle Array Fabrication by Photolithography

Published on: November 17, 2015

Related Experiment Videos

Last Updated: May 19, 2026

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices
08:26

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Published on: January 30, 2026

Polymeric Microneedle Array Fabrication by Photolithography
08:15

Polymeric Microneedle Array Fabrication by Photolithography

Published on: November 17, 2015

Main Results:

  • Keynote and invited lectures from leading researchers like Mark Prausnitz and Mark Kendall were presented.
  • The conference facilitated interdisciplinary communication among academic, industrial, and clinical delegates, promoting new collaborations.

Conclusions:

  • The conference underscored the rapid progress and diverse applications of microneedle technology.
  • It emphasized the growing importance of microneedles in advancing drug and vaccine delivery systems through collaborative efforts.